In this study, the regeneration of cancer cells in hepatocellular carcinoma (HCC) associated with calcium-independent phospholipase A2 (iPLA2) [193,194] was investigated using BER as the iPLA2 inhibitor [195], and DOX against this “Phoenix Rising”. This evidence concerns the gene PLA2G6 and hepatocellular carcinoma.